Cancer, Neurodegenerative Disease and Medicines Safety Feature in New IMI Call for Proposals
The Innovative Medicines Initiative (IMI) is launching a new Call for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU's Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners.
Read more ...
Commission Opens First European Innovation Council Calls Worth €1 Billion
Following the launch of the European Innovation Council (EIC) and the announcement of the first funding opportunities, today the Commission opened the first EIC Accelerator calls. The funding worth over €1 billion aims to help scale up start-ups and small and medium-sized businesses that have the potential to achieve high impact. While over half of the funding is open to breakthrough innovations in any field, €495 million are earmarked for innovations that support the European Green Deal as well as digital and health technologies.
Read more ...
DIATOMIC Launches its Final Call to Distribute up to €200K Equity-Free Funding
In its second and final open call for application experiments, DIATOMIC is offering a total of €1.610.000 equity-free funding plus acceleration services to the best startups/ SMEs and Competence Centers across the European microelectronics industry.
Read more ...
Ebola, Big Data, Childhood Cancers and Medicines Safety Feature in New IMI Call
The Innovative Medicines Initiative (IMI) has launched two Calls for proposals that will advance medicines development in critical areas such as Ebola, childhood cancers, neurological disorders, and eye disease. The Calls will also add to IMI's growing programme on Big Data for Better Outcomes.
Read more ...
EC Open Call FETOPEN-01-2016-2017: FET-Open Research and Innovation Actions
The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas. Here agile, risk-friendly and highly interdisciplinary research approaches are needed with collaborations that are open to all sciences and disciplines and that dissolve the traditional boundaries between them.
Read more ...
EC Open Call SC1-PM-15-2017: Personalised Coaching for Well-Being and Care of People as they Age
The activity aims at developing and validating radically new ICT based concepts and approaches for empowering and motivating people in need of guidance and care due to age related conditions, in cooperation with their carers where relevant, and to help them improve and maintain their independence, functional capacity, health status as well as preserving their physical, cognitive, mental and social well-being.
Read more ...
Erasmus for Young Entrepreneurs
Erasmus for Young Entrepreneurs is an exchange programme which gives entrepreneurs who intend to start a business or have recently started one the chance to learn from experienced owners of small businesses in other European Union countries.
Read more ...
The Innovative Medicines Initiative (IMI) is launching a new Call for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU's Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners. 
Following the launch of the European Innovation Council (EIC) and the announcement of the first funding opportunities, today the Commission opened the first EIC Accelerator calls. The funding worth over €1 billion aims to help scale up start-ups and small and medium-sized businesses that have the potential to achieve high impact. While over half of the funding is open to breakthrough innovations in any field, €495 million are earmarked for innovations that support the European Green Deal as well as digital and health technologies. 
The Innovative Medicines Initiative (IMI) has launched two Calls for proposals that will advance medicines development in critical areas such as Ebola, childhood cancers, neurological disorders, and eye disease. The Calls will also add to IMI's growing programme on Big Data for Better Outcomes.